Using whole transcriptome data derived from 703 primary melanomas from the Leeds Melanoma Cohort (LMC) [36], we found that ROR2 level is highest in tumors at the T1 stage and significantly higher than tumors at the T4 stage (Fig. 6A). The gene discussed is ROR2; the disease is melanoma.